Combining for a cure

It’s the smart combination of our cancer cell-directed and immuno-oncology approaches that may offer the greatest benefit for people living with cancer.

Article in the series

Science Stories

Taking KRAS Cancer On

Hear from Darryl McConnell, Research Site Head, Vienna, as he describes how we aim to drug all forms of KRAS

Combining for a cure

Article in the series

Taking KRAS Cancer On

Tags